Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Greg Howard
January 29, 2019
Donna Asbridge
January 29, 2019
Coping with Aspergillosis
January 29, 2019
Coping from a carers viewpoint…
January 29, 2019
Colin
January 29, 2019
Chip Chapman
January 29, 2019
Carol Saville
January 29, 2019
Becky Jones
January 29, 2019
Anne’s story
January 29, 2019
Abby Beats Serious Acute Aspergillosis and Leads a Normal Life
January 29, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video